Reuters: Money News: Teva asks U.S. justices for stay in Copaxone case

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Use GarageBand in Just 1 Hour Learn to create music in GarageBand and become the Beethoven you've wanted to be. This online course is just $30. Sign up today! From our sponsors

Teva asks U.S. justices for stay in Copaxone case Nov 5th 2013, 02:37 WASHINGTON (Reuters) - Teva Pharmaceutical Industries on Monday asked the U.S. Supreme Court to stay an appeals court ruling that would strip its $4 billion-a-year multiple sclerosis drug Copaxone of its patent protection in 2014 rather than 2015.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions